Sutro Biopharma Total Assets 2017-2022 | STRO

Sutro Biopharma total assets from 2017 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Sutro Biopharma Annual Total Assets
(Millions of US $)
2021 $341
2020 $394
2019 $156
2018 $223
2017 $41
2016 $69
Sutro Biopharma Quarterly Total Assets
(Millions of US $)
2022-03-31 $304
2021-12-31 $341
2021-09-30 $371
2021-06-30 $360
2021-03-31 $359
2020-12-31 $394
2020-09-30 $307
2020-06-30 $278
2020-03-31 $154
2019-12-31 $156
2019-09-30 $172
2019-06-30 $189
2019-03-31 $202
2018-12-31 $223
2018-09-30 $145
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2016-12-31 $69
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.216B $0.062B
Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.383B 9.82
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.475B 16.53
Biohaven Pharmaceutical Holding (BHVN) United States $9.944B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.681B 0.00
Emergent Biosolutions (EBS) United States $1.444B 6.18
Arcus Biosciences (RCUS) United States $1.389B 35.22
Myovant Sciences (MYOV) United Kingdom $0.879B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.509B 0.00
Gelesis Holdings (GLS) United States $0.362B 0.00
Zymeworks (ZYME) Canada $0.321B 0.00
Ambrx Biopharma (AMAM) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.114B 23.50
SQZ Biotechnologies (SQZ) United States $0.093B 0.00